ActHIB (haemophilus b conjugate vaccine) is an immunization used to prevent infection caused by haemophilus B bacteria, and is sometimes combined with vaccines to protect against other diseases. ActHIB vaccine will not protect against other types of influenza Indications and Usage for ActHIB. ActHIB is a vaccine indicated for the prevention of invasive disease caused by Haemophilus influenzae type b. ActHIB is approved for use in children 2 months through 5 years of age Act-HIB. Sponsor: Sanofi-Aventis Australia. Administration route: Intramuscular injection, Subcutaneous injection. Vaccine group: Monovalent vaccines. Registered for use in infants and children aged 2 months to 5 years. Monovalent Haemophilus influenzae type b (Hib) vaccine Generic Name: b Conjugate Vaccine (he MOF fi lus bee KON joo gate vak SEEN) Brand Name: ActHIB, Hiberix, PedvaxHIB. Medically reviewed by Drugs.com. Last updated on Nov 16, 2020. Overview. Side Effects. Dosage. Professional. Interactions
A HIB-oltás egy védőoltás a Haemophilus Influenzae baktérium B típusa ellen, amely elsősorban kisgyermekeknél okoz agyhártyagyulladást (Meningitis), valamint gyulladásos megbetegedéseket a fül-orr-gége területén (Epiglottitis). Kisgyermekek számára különösen ajánlják, mivel egyes Haemophilus Influenzae baktériumtörzsek mára immunissá váltak az ismert. Act-HIB is a vaccine that helps protect your child against Haemophilus influenzae type b infections. It does not provide protection against infections due to other types of Haemophilus influenzae or against cases of meningitis of other origins Act-HIB® [Haemophilus b Conjugate Vaccine (Tetanus Protein - Conjugate)] is a freeze-dried powder and diluent for intramuscular administration. Act-HIB® is prepared from Haemophilus influenzae type b (Hib) strain cultures and Clostridium tetani cultures. Hib strains are precipitated with cetrimide and capsular polysaccharide (PRP) is extracted
Act-HIB is usually stored in the doctor's surgery or clinic, or at the pharmacy. However, if you need to store Act-HIB: Keep out of the reach and sight of children. Keep Act-HIB in the original pack until it is time for it to be given. Store in a refrigerator (2°C - 8°C). Do not freeze. Freezing destroys the vaccine
Act-HIB® [Haemophilus b Conjugate Vaccine (Tetanus Protein - Conjugate)] is indicated for the active immunization of persons 2 months of age and older for the prevention of invasive disease caused by Haemophilus influenzae type b Haemophilus influenzae disease is a name for any illness caused by bacteria called H. influenzae.Some of these illnesses, like ear infections, are mild while others, like bloodstream infections, are very serious. In spite of the name, H. influenzae do not cause influenza (the flu).Vaccines can prevent one type of H. influenzae (type b or Hib) disease Uses. This vaccine helps protect young children from Haemophilus influenzae type b (Hib) infection. Hib is a bacterial infection that can cause serious illness, including brain infection. 5 In a US clinical trial (P3T06), 1,454 children were enrolled and received one dose of ActHIB 6 vaccine at 2 months of age and subsequent doses administered at 4 and 6 months of ag - Miért van szükség az Act-HIB oltásra? - Mit kell tudni az oltóanyagról? - Mik az ellenjavallatok, esetleges mellékhatások? Mi ellen véd a Hiberix oltás? A HIB a Haemophilus influenzae b baktérium nevének a rövidítése. Az influenza megnevezés nem jelenti, hogy a Haemophilus influenzae baktrérium az influenzavírus rokona
Sanofi Pasteur 095 - ActHIB® LE6677 Page 2 of 19 FULL PRESCRIBING INFORMATION: 1 INDICATIONS AND USAGE ActHIB is a vaccine indicated for the prevention of invasive disease caused by Haemophilus influenzae type b. ActHIB is approved for use in children 2 months through 5 years of age Act-HIB 10 micrograms/0.5 ml HAEMOPHILUS INFLUENZAE TYPE b VACCINE (CONJUGATED) Powder and solvent for solution for injection Act-HIB 10 microgrammes/0,5 ml VACCIN HAEMOPHILUS INFLUENZAE TYPE b (CONJUGUÉ) Poudre et solvant pour solution injectable La substance active est Description. Act-HIB is a Hib Conjugate Vaccine containing Haemophilus b capsular polysaccharide covalently linked to Tetanus toxoid. This vaccine is administered for active immunization against Haemophilus influenzae type b infections (meningitis, septicaemia, cellulitis, arthritis, epiglottitis, etc) in children aged from 2 months to 5 years Before your child receives this vaccine, tell the doctor about all other vaccines your child has recently received. Other drugs may interact with haemophilus b conjugate vaccine, including prescription and over-the-counter medicines, vitamins, and herbal products.Tell the doctor about all medications and treatments your child has recently received
Act-HIB . Haemophilus Typ B Konjugat-Impfstoff. Verwendung ab einem Lebensalter von 2 Monaten / Use from an age of 2 months. Sanofi Pasteur Europe . Mono: 482a/91: 11.05.1993: PharmNet.Bund. Wird derzeit in Deutschland nicht vermarktet. Act-HIB. Haemophilus Typ B Konjugat-Impfstof Act-HIB: Haemophilus b conjugate vaccine belongs to a group of medications known as vaccines. It is used to prevent invasive infections (e.g., meningitis) caused by the bacterium Haemophilus influenzae type b (Hib) in infants and children ages 2 months and older. It increases a child's defenses against Hib infections by stimulating the production of the child's own antibodies, which will. Act-HIB may have unwanted side effects in a few people. All medicines, including vaccines, can cause side effects. Sometimes they are serious, most of the time they are not
TETRAct-HIB contains Act-HIB (Haemophilus influenzae type b polysaccharide conjugated with tetanus protein) and D.T.COQ/D.T.P. (Purified diphtheria toxoid, Purified tetanus toxoid and killed whole cell Bordetella pertussis). This tetravalent combination vaccine is indicated for the prevention of invasive Haemophilus influenzae, type b infections. ACT HIB. Get Latest Price. SANOFI PASTEUR ActHIB ®, Haemophilus b Conjugate Vaccine (Tetanus Toxoid Conjugate), produced by Sanofi Pasteur SA, is a sterile, lyophilized powder which is reconstituted with either saline diluent (0.4% Sodium Chloride) or Tripedia®, Sanofi Pasteur Inc. Diphtheria and Tetanus Toxoids and Acellular Pertussis.
The Haemophilus influenzae type B vaccine, often called Hib vaccine, is a vaccine used to prevent Haemophilus influenzae type b (Hib) infection. In countries that include it as a routine vaccine, rates of severe Hib infections have decreased more than 90%. It has therefore resulted in a decrease in the rate of meningitis, pneumonia, and epiglottitis.. It is recommended by both the World Health. What should I discuss with my healthcare provider before taking this vaccine (ActHIB, Hiberix)? Your child should not receive this vaccine if he or she has ever had an allergic reaction to a haemophilus B or meningococcal vaccine.. If your child has any of these other conditions, this vaccine may need to be postponed or not given at all Act-HIB is a freeze-dried powder for reconstitution with diluent for injection. Following reconstitution, the solution is clear. Each pack of Act-HIB contains a single dose vial (containing powder for reconstitution) and 0.5 mL of diluent in a syringe. ACT-HIB® 3 Ingredient ActHIB is a vaccine that can be used alone or in combination to protect children against certain illnesses. This eMedTV segment describes this vaccination in detail, with information on how it is administered, possible side effects, and more Act-HIB and Hiberix. The product information for Act-HIB and Hiberix states that these vaccines are for use in children aged 2 months to 5 years. ATAGI recommends that the following people can also receive Act-HIB or Hiberix: older people with asplenia; people who have received an allogeneic or autologous haematopoietic stem cell transplan
medicatione.com conducted a study on Di-Te-Ki-Pol / Act-Hib, and the result of the survey is set out below. It is noteworthy that the product of the survey is based on the perception and impressions of the visitors of the website as well as the views of Di-Te-Ki-Pol / Act-Hib consumers HIB: The Disease. Haemophilus influenzae (H. influenzae) is a small gram-negative coccobacillus 1 found only in humans 2 and can be either encapsulated (typeable) or unencapsulated (nontypeable). H. influenzae type b (Hib) is transmitted by direct contact with respiratory secretions and enters the body through the upper respiratory tract. In most cases, Hib can remain in the mouth and nose for. Haemophilus influenzae type b infections (Hib) are widespread throughout the world. Hib infections may develop under various forms but meningitis is the most frequent one. Hib infections occur in children under the age of five years, and mostly during the first year of life
Hib and How to Protect Against It. Haemophilus influenzae type b (Hib) is a type of bacteria that can cause severe illness, including infections of the covering of the brain and spinal cord (meningitis), lung infections (pneumonia), and severe throat infections (epiglottitis). You can protect against Hib with safe, effective vaccination Hib disease used to be more common in the United States — about 20,000 children got serious Hib infections every year. Thanks to the vaccine, serious cases of Hib disease have dropped by more than 99% since 1991. There are 2 types of vaccines that protect against Hib disease Nos vaccins - FLUZONE HIGH DOSE QUADRIVALENT. Nom du produit : FLUZONE HIGH DOSE QUADRIVALENT Forme pharmaceutique : Suspension injectable en seringue préremplie DCI : Vaccin grippal quadrivalent (inactivé, à virion fragmenté), 60 microgrammes HA/souche Ce vaccin est mis à disposition dans le cadre d'une autorisation d'importation délivrée par l'ANSM pour la constitution d'un. This vaccine helps protect young children from Haemophilus influenzae type b (Hib) infection. Hib is a bacterial infection that can cause serious illness, including brain infection (meningitis) Act-Hib Solution is used for influenza, tetanus and other conditions
When Act-HIB is injected, the body's natural defenses develop a protection against those diseases. This vaccine is indicated for the prevention of Haemophilus influenzaetype b invasive infections (meningitis, septicaemia, cellulitis, arthritis, epiglottitis, etc.) in children from the age of 2 months Product: Act HIB New Manufacturer: Sanofi Pasteur Generic: Haemophilus b polysaccharide conjugate vaccine Type: Injection Strength: 0.5ml Packing: 5 Single-dose Vials with diluent for reconstitution Description: This vaccine prevents the children from the infection of Haemophilus influenza type b (HIB). Indication: Haemophilus influenza type b vaccin stituting the Act-HIB (Haemophilus influenzae type b conjugate) vaccine or administered sim-ultaneously with it in two separate injection sites. In case the child should receive Tetraxim simultaneously with other vaccines than those already mentioned, the doctor must be consulted for more information a) Act-HIB (Pasteur Mérieux) Fél évesnél fiatalabb csecsemők alapimmunizálása 3 oltásból áll, az oltások közötti intervallum 1-2 hónap. 6-12 hónapos csecsemők alapimmunizálásához két oltás elegendő, ugyancsak 1-2 hónapos intervallummal
Act Hib Injection is used for haemophilus influenzae type b infection, tetanus, tightening of body muscles and other conditions Act-HIB powder before use are mixed with the solvent by shaking, until a clear, colorless solution. Enter drug deep subcutaneous or intramuscular injection. A single dose of 0, 5 ml. Children under 2 years of solution is injected into the thigh - in the middle third of the anterolateral area. Children older than 2 years old - in the deltoid muscle
ACT-HIB: 5 x 0.5 mL vials / 5 fioles de 0,5 mL Resolved 2017-03-28: 2018-01-22: 4464: ACT-HIB: 5 x 0.5 mL vials Resolved 2020-03-04: 2020-05-13: 107680: Discontinuation reports. Brand name Packaging Size Status Date Created Date Updated Reports. This information is intended for Canadian residents. Listed below are all the products currently distributed by Sanofi Pasteur in Canada. The associated product monographs are intended solely for use by healthcare professionals in Canada Haemophilus influenzae is a group of bacteria that can cause mild to very serious illness, particularly in young children. The information on this page relates to the most common type, haemophilus influenza type b (Hib) disease
